vs
AMREP CORP.（AXR）与SUTRO BIOPHARMA, INC.（STRO）财务数据对比。点击上方公司名可切换其他公司
AMREP CORP.的季度营收约是SUTRO BIOPHARMA, INC.的1.3倍（$14.6M vs $11.6M），AMREP CORP.同比增速更快（93.8% vs -21.4%），过去两年SUTRO BIOPHARMA, INC.的营收复合增速更高（-5.4% vs -13.6%）
AMREP是一家总部位于美国新泽西州普林斯顿的企业，核心业务涵盖房地产与媒体服务领域。公司前身为美国地产石油公司，于1961年正式成立，在相关行业拥有六十余年的发展运营历史。
Sutro Biopharma是一家上市生物科技公司，总部位于加州南旧金山，专注于临床阶段药物的研发、开发与生产。公司依托自主专有的无细胞蛋白质合成平台，结合蛋白质工程与理性设计技术开发肿瘤治疗药物。公司2003年成立时名为Fundamental Applied Biology，2009年改用现名。
AXR vs STRO — 直观对比
营收规模更大
AXR
是对方的1.3倍
$11.6M
营收增速更快
AXR
高出115.1%
-21.4%
两年增速更快
STRO
近两年复合增速
-13.6%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $14.6M | $11.6M |
| 净利润 | $3.1M | — |
| 毛利率 | — | — |
| 营业利润率 | 20.6% | — |
| 净利率 | 21.6% | — |
| 营收同比 | 93.8% | -21.4% |
| 净利润同比 | 338.9% | 35.4% |
| 每股收益（稀释后） | $0.58 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXRSTRO
| Q1 26 | $14.6M | — | ||
| Q4 25 | $9.4M | $11.6M | ||
| Q3 25 | $17.9M | $9.7M | ||
| Q2 25 | $11.2M | $63.7M | ||
| Q1 25 | $7.5M | $17.4M | ||
| Q4 24 | $11.9M | $14.8M | ||
| Q3 24 | $19.1M | $8.5M | ||
| Q2 24 | $19.5M | $25.7M |
净利润AXRSTRO
| Q1 26 | $3.1M | — | ||
| Q4 25 | $1.2M | — | ||
| Q3 25 | $4.7M | $-56.9M | ||
| Q2 25 | $3.9M | $-11.5M | ||
| Q1 25 | $717.0K | $-76.0M | ||
| Q4 24 | $4.0M | $-72.4M | ||
| Q3 24 | $4.1M | $-48.8M | ||
| Q2 24 | $4.1M | $-48.0M |
营业利润率AXRSTRO
| Q1 26 | 20.6% | — | ||
| Q4 25 | 11.9% | — | ||
| Q3 25 | 34.4% | -499.9% | ||
| Q2 25 | 31.7% | -5.2% | ||
| Q1 25 | 5.7% | -393.8% | ||
| Q4 24 | 26.4% | -440.7% | ||
| Q3 24 | 26.1% | -797.2% | ||
| Q2 24 | 23.9% | -189.4% |
净利率AXRSTRO
| Q1 26 | 21.6% | — | ||
| Q4 25 | 12.8% | — | ||
| Q3 25 | 26.3% | -586.6% | ||
| Q2 25 | 34.8% | -18.0% | ||
| Q1 25 | 9.5% | -436.6% | ||
| Q4 24 | 33.9% | -489.2% | ||
| Q3 24 | 21.3% | -572.6% | ||
| Q2 24 | 21.2% | -186.8% |
每股收益（稀释后）AXRSTRO
| Q1 26 | $0.58 | — | ||
| Q4 25 | $0.22 | — | ||
| Q3 25 | $0.87 | $-0.67 | ||
| Q2 25 | $0.73 | $-0.14 | ||
| Q1 25 | $0.13 | $-0.91 | ||
| Q4 24 | $0.75 | $-27.63 | ||
| Q3 24 | $0.76 | $-0.59 | ||
| Q2 24 | $0.77 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $50.0M | $141.4M |
| 总债务越低越好 | $21.0K | — |
| 股东权益账面价值 | $139.4M | $-132.5M |
| 总资产 | $143.9M | $173.8M |
| 负债/权益比越低杠杆越低 | 0.00× | — |
8季度趋势，按日历期对齐
现金及短期投资AXRSTRO
| Q1 26 | $50.0M | — | ||
| Q4 25 | $44.6M | $141.4M | ||
| Q3 25 | $48.9M | $167.6M | ||
| Q2 25 | $39.5M | $205.1M | ||
| Q1 25 | $36.9M | $249.0M | ||
| Q4 24 | $40.1M | $316.9M | ||
| Q3 24 | $40.4M | $388.3M | ||
| Q2 24 | $29.7M | $375.6M |
总债务AXRSTRO
| Q1 26 | $21.0K | — | ||
| Q4 25 | $23.0K | — | ||
| Q3 25 | $25.0K | — | ||
| Q2 25 | $26.0K | — | ||
| Q1 25 | $29.0K | — | ||
| Q4 24 | $32.0K | — | ||
| Q3 24 | $34.0K | — | ||
| Q2 24 | $35.0K | — |
股东权益AXRSTRO
| Q1 26 | $139.4M | — | ||
| Q4 25 | $136.0M | $-132.5M | ||
| Q3 25 | $134.7M | $-87.3M | ||
| Q2 25 | $130.0M | $-32.1M | ||
| Q1 25 | $126.0M | $-25.8M | ||
| Q4 24 | $125.1M | $44.6M | ||
| Q3 24 | $122.2M | $111.2M | ||
| Q2 24 | $118.0M | $152.2M |
总资产AXRSTRO
| Q1 26 | $143.9M | — | ||
| Q4 25 | $140.1M | $173.8M | ||
| Q3 25 | $140.7M | $209.7M | ||
| Q2 25 | $133.8M | $262.4M | ||
| Q1 25 | $128.9M | $321.4M | ||
| Q4 24 | $129.1M | $387.2M | ||
| Q3 24 | $127.0M | $451.8M | ||
| Q2 24 | $122.8M | $489.0M |
负债/权益比AXRSTRO
| Q1 26 | 0.00× | — | ||
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $5.4M | $-177.2M |
| 自由现金流经营现金流 - 资本支出 | $5.4M | — |
| 自由现金流率自由现金流/营收 | 37.0% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | 1.72× | — |
| 过去12个月自由现金流最近4个季度 | $20.2M | — |
8季度趋势，按日历期对齐
经营现金流AXRSTRO
| Q1 26 | $5.4M | — | ||
| Q4 25 | $-4.3M | $-177.2M | ||
| Q3 25 | $9.5M | $-38.2M | ||
| Q2 25 | $10.2M | $-44.7M | ||
| Q1 25 | $-3.2M | $-67.9M | ||
| Q4 24 | $-182.0K | $-71.7M | ||
| Q3 24 | $10.7M | $-64.5M | ||
| Q2 24 | $10.7M | $9.5M |
自由现金流AXRSTRO
| Q1 26 | $5.4M | — | ||
| Q4 25 | $-4.3M | — | ||
| Q3 25 | $9.5M | — | ||
| Q2 25 | $9.7M | — | ||
| Q1 25 | $-3.3M | — | ||
| Q4 24 | $-268.0K | — | ||
| Q3 24 | $10.7M | — | ||
| Q2 24 | $10.3M | — |
自由现金流率AXRSTRO
| Q1 26 | 37.0% | — | ||
| Q4 25 | -45.9% | — | ||
| Q3 25 | 53.2% | — | ||
| Q2 25 | 86.4% | — | ||
| Q1 25 | -43.4% | — | ||
| Q4 24 | -2.3% | — | ||
| Q3 24 | 55.8% | — | ||
| Q2 24 | 52.5% | — |
资本支出强度AXRSTRO
| Q1 26 | 0.1% | — | ||
| Q4 25 | 0.6% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 5.2% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 0.7% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 2.3% | — |
现金转化率AXRSTRO
| Q1 26 | 1.72× | — | ||
| Q4 25 | -3.54× | — | ||
| Q3 25 | 2.03× | — | ||
| Q2 25 | 2.63× | — | ||
| Q1 25 | -4.51× | — | ||
| Q4 24 | -0.05× | — | ||
| Q3 24 | 2.63× | — | ||
| Q2 24 | 2.59× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
